After PEPFAR withdrawal, 20% of facilities across multiple districts reported challenges with HIV testing; 47% of patients who attended a health facility were not offered HIV testing, which is critical to identify people who are living with HIV, need to start and restart treatment, or identify those who may need prevention services.

Date: 10/25

Region: Africa

Country: South Africa

Topic: Health

Policy Lens: Global Health Security

Additional Context: In October 2025, Ritshidze released a report on the national state of health in 2025. Ritshidze is a community-led monitoring system implemented by the Treatment Action Campaign (TAC). Since 2018, Ritshidze has been consistently collecting data across sites in 26 PEPFAR priority districts. Following the PEPFAR funding cuts, monitoring is now continuing in 17 districts. As part of this reporting, a new tool was deployed to survey patients as they exit the clinic in order to gather evidence for the state of service provision on that exact day.

All Ritshidze data collection tools and data dashboard are available here.

Source: Ritshidze

Devex Researcher Note: Antiretroviral Therapy (ART) is a combination of medications used to treat and manage Human Immunodeficiency Virus (HIV) infection.